Exciting liquid biopsy data from #AACR26 in extensive stage-#SCLC - a disease where better biomarkers are desperately needed.
The LUMINANCE study (NCT04774380) used the GRAIL Portrait tumor-agnostic, methylation-based #ctDNA #liquidbiopsy assay to track treatment response to